Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer

NCT07095023 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancers

Interventions

DRUG: Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]